Drug Profile
Tc 99m ethylenedicysteine amifostine - CellPoint
Alternative Names: (99m)Tc ethylenedicysteine amifostine; 99mTc ethylenedicysteine amifostine; 99mTc-EC-amifostine; Ethylenedicysteine amifostine-Tc-99m; Technetium 99m ethylenedicysteine amifostineLatest Information Update: 30 Mar 2020
Price :
$50
*
At a glance
- Originator CellPoint
- Class Chemoprotectants; Diagnostic conjugates; Organotechnetium compounds; Organothiophosphorus compounds; Radiopharmaceutical diagnostics; Small molecules; Technetium compounds
- Mechanism of Action Ionising radiation emitters; Oxygen radical scavengers; Positron-emission tomography enhancers; Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; COVID 2019 infections
Most Recent Events
- 24 Mar 2020 Early research in Cancer (Diagnosis) in USA (Parenteral) before March 2020
- 24 Mar 2020 Early research in COVID-2019 infections (Diagnosis) in USA (Parenteral) before March 2020
- 24 Mar 2020 Early research in COVID-2019 infections in USA (Parenteral) before March 2020